Abstract
In the largest purchase of a cancer-focused biopharmaceutical company since Roche bought Genentech in 2009, Amgen, of Thousand Oaks, CA, will buy Onyx Pharmaceuticals, of South San Francisco, CA, for $10.4 billion.
- ©2013 American Association for Cancer Research.
October 2013
Volume 3, Issue 10
Volume 3, Issue 10
Amgen to Buy Onyx for $10.4 Billion
Jump to section
Advertisement